To ask the Secretary of State for Health and Social Care, if he will make an estimate of (a) the potential cost savings of improving early identification and treatment of Kawasaki disease and (b) the potential consequent reduction in demand for long-term specialist care for children with that disease.

The requested information is not available and therefore no such estimate has been made.

NHS Improvement has previously published a Patient Safety Alert for the attention of providers of National Health Service-funded care to emphasise the high risk and atypical presentation of coronary artery aneurysms, coronary thrombosis and myocardial ischaemia or infarction in patients with Kawasaki disease, and to highlight the importance of specialist advice.

Guidance is also available from the National Institute for Health and Care Excellence (NICE) on the assessment and initial management of fever in children under five, and this guidance includes recommendations on recognising the symptoms of Kawasaki disease.